Treatment of hypovolaemia caused by acute blood loss.
For use in elective surgery patients, trauma patients, patients undergoing open-heart surgery in association with cardiopulmonary bypass, where alternative infusion solutions are not considered to be sufficient.
Kidney function should be monitored at least 90 days and blood coagulation parameter should be closely monitored.